Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Meisner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Open Forum Infectious Diseases|November 18, 2024
Implementation of Injectable Cabotegravir/Rilpivirine for Treatment of Human Immunodeficiency Virus in Patients With Substance Use Disorders at a Syringe Exchange ClinicAmanda Perez, Shane Nieves, Jessica Meisner
Studies in Health Technology and Informatics|November 22, 2024
Use and Evaluation of GANs for Synthetic Data Generation in PharmacogeneticsDominic Aeschbacher, Jessica Meisner, Marko Miletic, et al.
Microbiology Spectrum|December 20, 2022
Evaluation of Dalbavancin Use on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net HospitalRichard Lueking, Wenjing Wei, Norman S Mang, et al.
Substance Use & Addiction Journal|October 28, 2024
Psychosocial Impact of Suspected Xylazine-Associated Skin Wounds Among People Using Fentanyl, Philadelphia, 2022 to 2023Patrick J A Kelly, Amy B Jessop, Madison Scialanca, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Open Forum Infectious Diseases|November 18, 2024
Implementation of Injectable Cabotegravir/Rilpivirine for Treatment of Human Immunodeficiency Virus in Patients With Substance Use Disorders at a Syringe Exchange ClinicAmanda Perez, Shane Nieves, Jessica Meisner
Studies in Health Technology and Informatics|November 22, 2024
Use and Evaluation of GANs for Synthetic Data Generation in PharmacogeneticsDominic Aeschbacher, Jessica Meisner, Marko Miletic, et al.
Microbiology Spectrum|December 20, 2022
Evaluation of Dalbavancin Use on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net HospitalRichard Lueking, Wenjing Wei, Norman S Mang, et al.
Substance Use & Addiction Journal|October 28, 2024
Psychosocial Impact of Suspected Xylazine-Associated Skin Wounds Among People Using Fentanyl, Philadelphia, 2022 to 2023Patrick J A Kelly, Amy B Jessop, Madison Scialanca, et al.
Pageof 1